Dr. Ibrahim earned undergraduate degrees in biochemistry and microbiology from the University of Kuwait, and a Ph.D. in microbial physiology from the Loughborough University of Technology in England.  He completed a fellowship in molecular mycological pathogenesis at Harbor-UCLA Medical Center.  Dr. Ibrahim is Professor of Medicine, David Geffen School of Medicine at UCLA, and an Infectious Disease Faculty member at Harbor-UCLA Medical Center. His research advances the understanding of pathogenic mechanisms and virulence factors of fungal and bacterial pathogens, and on translating this knowledge into novel strategies to combat infection.  Dr. Ibrahim holds several research grants, including NIH and industry-sponsored projects.  His program to study the role of iron uptake in the pathogenesis of mucormycosis sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) is leading the way to new therapies for this often fatal infection.  Dr. Ibrahim has co-authored over 80 peer-reviewed research papers, book chapters and review articles and serves as reviewer for peer-reviewed journals.  He is a member of Faculty 1000 and currently has served as a member of the Pathogenic Eukaryotes NIH Study Section. Recently, Dr. Ibrahim received the prestigious Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Program Committee Award in the area of Therapy and Prevention of Microbial Disease.

Publications